Sei Investments CO Chimerix Inc Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $3,194 - $4,871	-1,765 Reduced 2.25%	76,822 $148,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $105,306 - $419,654	78,587 New	78,587 $163,000
Q3 2018 Nov 08, 2018	SELL	$3.58 - $4.9 $429 - $588	-120 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$4.43 - $5.14 $434 - $503	98 Added 445.45%	120 $1,000
Q3 2017 Nov 06, 2017	BUY	$4.35 - $5.25 $95 - $115	22	22 $0

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.